Unleashing the Power of PROs in Oncology Trials
In this webinar we explore the benefits of incorporating PROs in early phase oncology trials to inform optimal dose determination.
In this webinar we explore the benefits of incorporating PROs in early phase oncology trials to inform optimal dose determination.
Discover the FDA's draft guidance on oncology PROs and its impact on trial design, data collection, patient experience, and outcomes.
Explore recent FDA guidance on PROs in oncology trials and learn how to enhance PRO data for labeling claims.